Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,843 | -28,030 | -17,474 | -7,904 | -29,491 |
| Depreciation Amortization | 389 | 340 | 243 | 88 | 381 |
| Accounts payable and accrued liabilities | 1,605 | 852 | 512 | 206 | -263 |
| Other Working Capital | 1,613 | -362 | 1,000 | -1,175 | -2,677 |
| Other Operating Activity | 5,209 | 4,322 | 3,023 | 1,599 | 4,693 |
| Operating Cash Flow | $-33,027 | $-22,878 | $-12,696 | $-7,186 | $-27,357 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -435 | -432 | -417 | -168 | -170 |
| Investing Cash Flow | $-435 | $-432 | $-417 | $-168 | $-170 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,398 | -2,199 | N/A | N/A | N/A |
| Common Stock Issued | 28,898 | 8,747 | 5,007 | 450 | 35,602 |
| Financing Cash Flow | $24,500 | $6,548 | $5,007 | $450 | $35,602 |
| Beginning Cash Position | 39,673 | 39,673 | 39,673 | 39,673 | 31,598 |
| End Cash Position | 30,711 | 22,911 | 31,567 | 32,769 | 39,673 |
| Net Cash Flow | $-8,962 | $-16,762 | $-8,106 | $-6,904 | $8,075 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,027 | -22,878 | -12,696 | -7,186 | -27,357 |
| Capital Expenditure | -435 | -432 | -417 | -168 | -170 |
| Free Cash Flow | -33,462 | -23,310 | -13,113 | -7,354 | -27,527 |